Refine by
Liver Disease Technology
32 companies found
Technologybased inAnn Arbor, MICHIGAN (USA)
ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS) platform to enable clinicians to visualize human tissue composition, function and ...
Technologybased inMunich, GERMANY
Isarna Therapeutics was built on profound knowledge in antisense oligonucleotide design and therapeutic development of this innovative compound class. Today, Isarna is developing a portfolio of antisense therapies targeting an emerging therapeutic ...
Technologybased inVancouver, BRITISH COLUMBIA (CANADA)
Sonic Incytes is redefining the standard of care in quantifying liver stiffness and attenuation. Recognizing the rise of fatty liver disease, we’ve made it our mission to make liver health a new vital sign. Our novel, portable, handheld solution ...
Velacur is a portable, handheld ultrasound that integrates a live ultrasound image, resulting in an assessment of liver stiffness and attenuation, components of liver fibrosis and fat measurements. It generates real-time stiffness measurements at ...
Technologybased inRochester, MINNESOTA (USA)
Cytotheryx, Inc. is a preclinical cell therapy company focused on the development of a readily available, consistent and high-quality source of primary human hepatocytes (liver cells) and the use of those cells for research and clinical ...
At Cytotheryx, we understand that life-saving discovery in liver disease research and medicine requires a multi-faceted approach. The key to enabling this innovation is a reliable foundation. We understand this need and the opportunity to support ...
Technologybased inTübingen, GERMANY
HepaRegeniX GmbH is a clinical stage company developing novel therapies for the treatment of acute and chronic liver diseases. Since its start in 2017, HepaRegeniX has successfully discovered and developed several drug candidates for the treatment ...
Liver diseases are characterized by a gradual deterioration of the liver function, and, on a molecular level, by a reorganization and destruction of liver tissue. Several disease stages characterize the path from the healthy liver to a fully ...
Technologybased inGaithersburg, MARYLAND (USA)
Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s lead product candidate, pemvidutide, is a GLP-1/glucagon dual ...
A peptide-based dual GLP-1/glucagon receptor agonist designed to treat the metabolic dysfunction that causes non-alcoholic steatohepatitis (NASH). NASH, the most severe form of non-alcoholic fatty liver disease (NAFLD), involves multiple ...
Technologybased inAix-en-Provence, FRANCE
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a new generation ultrasound system, Aixplorer, with an UltraFast platform that can ...
SuperSonic Imagine holds 30 international patent families protecting its unique ultrasound imaging technology around the ...
Technologybased inFoster City, CALIFORNIA (USA)
Gilead is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the ...
Ledipasvir 90 mg/sofosbuvir 400 mg. Harvoni® is indicated for the treatment of adults and pediatric patients ≥3 years with chronic hepatitis C virus (HCV) genotype 1, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis. ...
Technologybased inOldsmar, FLORIDA (USA)
VetBiotek provides innovative solutions for veterinary medicine. The VetBiotek management team has over 200 years of cumulative experience in the veterinary marketplace. Our goal is to bring the most advanced, novel ingredients to the veterinary ...
Technologybased inCambridge, MASSACHUSETTS (USA)
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP ...
Technologybased inShanghai, CHINA
RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable ...
Chronic kidney disease (CKD) is a non-communicable disease usually caused by diabetes and hypertension. The prevalence of chronic kidney disease in China is reported to be 10.8%, and is predicted to increase in the next decade, especially among ...
Technologybased inDoylestown, PENNSYLVANIA (USA)
ImCare Biotech is a biotechnology company founded in 2011 by Dr. Xuanyong Lu, formerly a professor at Drexel University’s Institute for Biotechnology and Virology. The company’s primary products in development are innovative diagnostic biomarkers as ...
Technologybased inMerion, PENNSYLVANIA (USA)
Glycotest is a liver disease diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis. Founded in 2012 by NetScientific plc on technology originating at the Baruch S. Blumberg ...
Glycotest blood tests are being developed to provide information on the likelihood of serious liver disease like cancer or fibrosis-cirrhosis by employing technology designed to measure two kinds of disease signals: The amount of the monosaccharide ...
Technologybased inSint-Denijs Westrem, BELGIUM
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
Liver disease, a large and growing market globally. Cirrhosis is late-stage liver disease which occurs when scar tissue (fibrosis) replaces healthy tissue. Alcohol and viral hepatitis B and C are common causes of cirrhosis, although there are many ...
Technologybased inRochester, MINNESOTA (USA)
Resoundant, Inc. is a medical technology company founded by Mayo Foundation for Medical Education and Research and is located in Rochester, MN. Resoundant is dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance ...
Resoundant offers Core Lab services in collaboration with the Mayo Clinic scientists and medical professionals who invented MR Elastography over 20 years ago. Today, Resoundant and Mayo Clinic continue to support the ongoing advancement of MRE ...
Technologybased inshenzhen, CHINA
Span Biotech Ltd. is a research based company for rapid tests, with strong support from National Key Laboratory of Technology Projects of 10th and 11th Five-Year Plan and Faculty of Life Sciences of HuBei University. SpanBio also housed a R&D team ...
Technologybased inPoway, CALIFORNIA (USA)
Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...
Technologybased inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
Technologybased inGüngören, TURKEY
From its establishment in 2002 to the present, Dollvet has sensitively focused on importance of technical infrastructure, equipment, large staff and human resources. As of 2019, more than half of over 150 employees consists of experts that highly ...
Pharmaceutical Form :Injectable Solution. It is applied for protection in sheep and goats against Enterotoxemia and Infectious Necrotic Hepatitis, In Lambs and kids against Enterotoxemia, In cattle against Enterotoxemia and Blackleg ...
Technologybased inBuk-gu, SOUTH KOREA
JD Bioscience (JDB) is a group of experts in small molecule-based novel drug development. JD Bioscience was established by a team of highly experienced medicinal chemists, biologists, and clinicians in the field of endocrine and metabolic diseases. ...
NASH, an advanced form of non-alcoholic fatty liver disease (NAFLD), can progress to liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Genetic factors, environmental factors, and microbiome alterations are mainly involved in disease ...